Japan is leading the way in developing and taking Regenerative Medicine to market. Here is a pretty list of the players in this space.
I feel the the US will need to step up their game and compete with a fast tracked Japan.
MSB stands to attract increased interest from both the US and Japan with regard to their tier 1 and late stage products.
I place a speculative buy on MSB at these levels and will be buying! DYOR
Japan is leading the way in developing and taking Regenerative...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.29 |
Change
0.005(0.39%) |
Mkt cap ! $1.467B | |||
| Open | High | Low | Value | Volume |
| $1.29 | $1.31 | $1.27 | $1.653M | 1.285M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 16781 | $1.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.29 | 9777 | 1 |
View Market Depth
| Last trade - 16.10pm 05/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |